NCT03214510View on ClinicalTrials.gov

Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery

PHASE3RecruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

October 4, 2017

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Liver and Intrahepatic Bile Duct Disorder
Interventions
DRUG

Bupivacaine

Given via thoracic epidural catheter or TAP block

DRUG

Fentanyl

Given via thoracic epidural catheter

DRUG

Hydromorphone Hydrochloride

Given via thoracic epidural catheter

DEVICE

Implanted Medical Device

Undergo placement of thoracic epidural catheter

DEVICE

Implanted Medical Device

Undergo placement of ultrasound-guided, four-quadrant transversus abdominus plane block

DRUG

Liposomal Bupivacaine

Given via TAP block

BEHAVIORAL

Questionnaire

Ancillary studies

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER